Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Guangdong Medical University currently has 1 pending office action in the Biotechnology & Pharmaceuticals technology area. This action is assigned to 1 distinct examiner, JONES-FOSTER, ERICA NICOLE, who is the busiest examiner with 1 busiest examiner pending office action. The prosecution is localized in 1 distinct art unit, which simplifies the technical scope of the pending matters. This focus within 1 distinct art unit eliminates the need to manage diverse procedural expectations from multiple examiners.
With only 1 pending office action, the applicant's current engagement with the patent office is highly concentrated. The practitioner can tailor their arguments to the specific preferences of 1 distinct examiner. This streamlined profile suggests a targeted approach to securing patent rights. By focusing on the 1 busiest examiner pending office action, the legal team can more effectively address the specific rejections or objections raised. The presence of 1 pending office action allows for a dedicated response strategy that accounts for the current status of the portfolio.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JONES-FOSTER, ERICA NICOLE | 1 | 50.0% | +38.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18332489 | LONG-ACTING RECOMBINANT INTERLEUKIN-18 BINDING PROTEIN AND PRODUCTION METHOD AND APPLICATION THEREOF | JONES-FOSTER, ERICA NICOLE | 117d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18332489 | LONG-ACTING RECOMBINANT INTERLEUKIN-18 BINDING PROTEIN AND PRODUCTION METHOD AND APPLICATION THEREOF | JONES-FOSTER, ERICA NICOLE | 117d overdue |
| Art Unit | Apps |
|---|---|
| 1656 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18332489 | LONG-ACTING RECOMBINANT INTERLEUKIN-18 BINDING PROTEIN AND PRODUCTION METHOD AND APPLICATION THEREOF | JONES-FOSTER, ERICA NICOLE | 1656 | §103§112 | Non-Final OA | 117d overdue | Pending | Jun 09, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialGuangdong Medical University has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Erica Nicole Jones-Foster has the most, with 1 of Guangdong Medical University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.